nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—SLC28A3—Gemcitabine—kidney cancer	0.316	1	CbGbCtD
Adenosine—Cytarabine—Gemcitabine—kidney cancer	0.163	0.35	CrCrCtD
Adenosine—Azacitidine—Gemcitabine—kidney cancer	0.155	0.333	CrCrCtD
Adenosine—Decitabine—Gemcitabine—kidney cancer	0.148	0.317	CrCrCtD
Adenosine—Adenosine triphosphate—APAF1—kidney cancer	0.00163	0.468	CrCbGaD
Adenosine—ADA—renal system—kidney cancer	0.0015	0.0786	CbGeAlD
Adenosine—ADK—nephron tubule—kidney cancer	0.00135	0.0707	CbGeAlD
Adenosine—DPP4—nephron tubule—kidney cancer	0.0013	0.0685	CbGeAlD
Adenosine—ADK—renal system—kidney cancer	0.00122	0.0642	CbGeAlD
Adenosine—ADORA2A—gonad—kidney cancer	0.00122	0.0641	CbGeAlD
Adenosine—Adenosine monophosphate—APRT—kidney cancer	0.00122	0.347	CrCbGaD
Adenosine—DPP4—renal system—kidney cancer	0.00119	0.0623	CbGeAlD
Adenosine—ADK—kidney—kidney cancer	0.00118	0.0621	CbGeAlD
Adenosine—ADORA1—renal system—kidney cancer	0.00118	0.0618	CbGeAlD
Adenosine—ADK—cortex of kidney—kidney cancer	0.00115	0.0605	CbGeAlD
Adenosine—DPP4—kidney—kidney cancer	0.00115	0.0602	CbGeAlD
Adenosine—ADORA1—kidney—kidney cancer	0.00114	0.0597	CbGeAlD
Adenosine—DPP4—cortex of kidney—kidney cancer	0.00112	0.0586	CbGeAlD
Adenosine—ADORA1—cortex of kidney—kidney cancer	0.00111	0.0581	CbGeAlD
Adenosine—ADK—gonad—kidney cancer	0.0011	0.0576	CbGeAlD
Adenosine—ADK—cardiac atrium—kidney cancer	0.0011	0.0575	CbGeAlD
Adenosine—ADORA1—cardiac atrium—kidney cancer	0.00105	0.0553	CbGeAlD
Adenosine—Adenosine triphosphate—ALK—kidney cancer	0.000569	0.163	CrCbGaD
Adenosine—Acute coronary syndrome—Paclitaxel—kidney cancer	0.000198	0.00163	CcSEcCtD
Adenosine—Myocardial infarction—Paclitaxel—kidney cancer	0.000197	0.00162	CcSEcCtD
Adenosine—Dyspnoea—Erlotinib—kidney cancer	0.000196	0.00161	CcSEcCtD
Adenosine—Pain—Vinblastine—kidney cancer	0.000196	0.00161	CcSEcCtD
Adenosine—Atrioventricular block—Doxorubicin—kidney cancer	0.000196	0.00161	CcSEcCtD
Adenosine—Pain—Everolimus—kidney cancer	0.000195	0.0016	CcSEcCtD
Adenosine—Vomiting—Temsirolimus—kidney cancer	0.000195	0.0016	CcSEcCtD
Adenosine—Shock—Sorafenib—kidney cancer	0.000195	0.0016	CcSEcCtD
Adenosine—Dry mouth—Sunitinib—kidney cancer	0.000194	0.0016	CcSEcCtD
Adenosine—Mediastinal disorder—Gemcitabine—kidney cancer	0.000194	0.0016	CcSEcCtD
Adenosine—Rash—Temsirolimus—kidney cancer	0.000193	0.00159	CcSEcCtD
Adenosine—Dermatitis—Temsirolimus—kidney cancer	0.000193	0.00159	CcSEcCtD
Adenosine—Arrhythmia—Gemcitabine—kidney cancer	0.000192	0.00158	CcSEcCtD
Adenosine—Headache—Temsirolimus—kidney cancer	0.000192	0.00158	CcSEcCtD
Adenosine—Dizziness—Pazopanib—kidney cancer	0.000191	0.00157	CcSEcCtD
Adenosine—Back pain—Vincristine—kidney cancer	0.000191	0.00157	CcSEcCtD
Adenosine—Ventricular tachycardia—Doxorubicin—kidney cancer	0.00019	0.00156	CcSEcCtD
Adenosine—Injection site reaction—Doxorubicin—kidney cancer	0.000189	0.00155	CcSEcCtD
Adenosine—Pain—Erlotinib—kidney cancer	0.000188	0.00155	CcSEcCtD
Adenosine—Shock—Sunitinib—kidney cancer	0.000188	0.00154	CcSEcCtD
Adenosine—Discomfort—Dactinomycin—kidney cancer	0.000186	0.00153	CcSEcCtD
Adenosine—Vomiting—Pazopanib—kidney cancer	0.000184	0.00151	CcSEcCtD
Adenosine—Bradycardia—Paclitaxel—kidney cancer	0.000183	0.00151	CcSEcCtD
Adenosine—Rash—Pazopanib—kidney cancer	0.000182	0.0015	CcSEcCtD
Adenosine—Nausea—Temsirolimus—kidney cancer	0.000182	0.0015	CcSEcCtD
Adenosine—Dermatitis—Pazopanib—kidney cancer	0.000182	0.0015	CcSEcCtD
Adenosine—Bronchospasm—Capecitabine—kidney cancer	0.000182	0.00149	CcSEcCtD
Adenosine—Agitation—Vincristine—kidney cancer	0.000182	0.00149	CcSEcCtD
Adenosine—Back pain—Gemcitabine—kidney cancer	0.000181	0.00149	CcSEcCtD
Adenosine—Headache—Pazopanib—kidney cancer	0.000181	0.00149	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00018	0.00148	CcSEcCtD
Adenosine—Hypoaesthesia—Paclitaxel—kidney cancer	0.000179	0.00147	CcSEcCtD
Adenosine—Abdominal discomfort—Capecitabine—kidney cancer	0.000177	0.00146	CcSEcCtD
Adenosine—Dyspnoea—Sorafenib—kidney cancer	0.000177	0.00145	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000174	0.00143	CcSEcCtD
Adenosine—Nausea—Pazopanib—kidney cancer	0.000172	0.00141	CcSEcCtD
Adenosine—Paraesthesia—Sunitinib—kidney cancer	0.000171	0.00141	CcSEcCtD
Adenosine—Convulsion—Vincristine—kidney cancer	0.000171	0.00141	CcSEcCtD
Adenosine—Hypertension—Vincristine—kidney cancer	0.000171	0.0014	CcSEcCtD
Adenosine—Dyspnoea—Sunitinib—kidney cancer	0.00017	0.0014	CcSEcCtD
Adenosine—Pain—Sorafenib—kidney cancer	0.000169	0.00139	CcSEcCtD
Adenosine—Hypersensitivity—Vinblastine—kidney cancer	0.000169	0.00139	CcSEcCtD
Adenosine—Hypersensitivity—Everolimus—kidney cancer	0.000168	0.00138	CcSEcCtD
Adenosine—Tinnitus—Paclitaxel—kidney cancer	0.000168	0.00138	CcSEcCtD
Adenosine—Cardiac disorder—Paclitaxel—kidney cancer	0.000167	0.00138	CcSEcCtD
Adenosine—Flushing—Paclitaxel—kidney cancer	0.000167	0.00138	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000164	0.00135	CcSEcCtD
Adenosine—Asthenia—Vinblastine—kidney cancer	0.000164	0.00135	CcSEcCtD
Adenosine—Asthenia—Everolimus—kidney cancer	0.000164	0.00135	CcSEcCtD
Adenosine—Cough—Gemcitabine—kidney cancer	0.000164	0.00134	CcSEcCtD
Adenosine—Pain—Sunitinib—kidney cancer	0.000163	0.00134	CcSEcCtD
Adenosine—Mediastinal disorder—Paclitaxel—kidney cancer	0.000162	0.00134	CcSEcCtD
Adenosine—Acute coronary syndrome—Capecitabine—kidney cancer	0.000162	0.00134	CcSEcCtD
Adenosine—Hypertension—Gemcitabine—kidney cancer	0.000162	0.00133	CcSEcCtD
Adenosine—Myocardial infarction—Capecitabine—kidney cancer	0.000161	0.00133	CcSEcCtD
Adenosine—Anaphylactic shock—Vincristine—kidney cancer	0.000161	0.00133	CcSEcCtD
Adenosine—Arrhythmia—Paclitaxel—kidney cancer	0.000161	0.00132	CcSEcCtD
Adenosine—Chest pain—Gemcitabine—kidney cancer	0.00016	0.00131	CcSEcCtD
Adenosine—Asthenia—Erlotinib—kidney cancer	0.000158	0.0013	CcSEcCtD
Adenosine—Discomfort—Gemcitabine—kidney cancer	0.000158	0.0013	CcSEcCtD
Adenosine—Urticaria—Sorafenib—kidney cancer	0.000157	0.00129	CcSEcCtD
Adenosine—Hyperhidrosis—Vincristine—kidney cancer	0.000156	0.00128	CcSEcCtD
Adenosine—Pain—Dactinomycin—kidney cancer	0.000154	0.00127	CcSEcCtD
Adenosine—Tension—Paclitaxel—kidney cancer	0.000154	0.00127	CcSEcCtD
Adenosine—Dysgeusia—Paclitaxel—kidney cancer	0.000154	0.00126	CcSEcCtD
Adenosine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000153	0.00126	CcSEcCtD
Adenosine—Nervousness—Paclitaxel—kidney cancer	0.000152	0.00125	CcSEcCtD
Adenosine—Back pain—Paclitaxel—kidney cancer	0.000152	0.00125	CcSEcCtD
Adenosine—Dizziness—Vinblastine—kidney cancer	0.000151	0.00125	CcSEcCtD
Adenosine—Dizziness—Everolimus—kidney cancer	0.000151	0.00124	CcSEcCtD
Adenosine—Hypotension—Vincristine—kidney cancer	0.000151	0.00124	CcSEcCtD
Adenosine—Bradycardia—Capecitabine—kidney cancer	0.000151	0.00124	CcSEcCtD
Adenosine—Vision blurred—Paclitaxel—kidney cancer	0.000148	0.00122	CcSEcCtD
Adenosine—Hyperhidrosis—Gemcitabine—kidney cancer	0.000148	0.00122	CcSEcCtD
Adenosine—Hypoaesthesia—Capecitabine—kidney cancer	0.000147	0.00121	CcSEcCtD
Adenosine—Tremor—Paclitaxel—kidney cancer	0.000147	0.00121	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000147	0.00121	CcSEcCtD
Adenosine—Hypersensitivity—Sorafenib—kidney cancer	0.000146	0.0012	CcSEcCtD
Adenosine—Vomiting—Vinblastine—kidney cancer	0.000146	0.0012	CcSEcCtD
Adenosine—Dizziness—Erlotinib—kidney cancer	0.000146	0.0012	CcSEcCtD
Adenosine—Vomiting—Everolimus—kidney cancer	0.000145	0.00119	CcSEcCtD
Adenosine—Paraesthesia—Vincristine—kidney cancer	0.000145	0.00119	CcSEcCtD
Adenosine—Agitation—Paclitaxel—kidney cancer	0.000144	0.00119	CcSEcCtD
Adenosine—Rash—Everolimus—kidney cancer	0.000144	0.00118	CcSEcCtD
Adenosine—Dermatitis—Everolimus—kidney cancer	0.000144	0.00118	CcSEcCtD
Adenosine—Headache—Vinblastine—kidney cancer	0.000143	0.00118	CcSEcCtD
Adenosine—Angioedema—Paclitaxel—kidney cancer	0.000143	0.00118	CcSEcCtD
Adenosine—Headache—Everolimus—kidney cancer	0.000143	0.00118	CcSEcCtD
Adenosine—Hypotension—Gemcitabine—kidney cancer	0.000143	0.00118	CcSEcCtD
Adenosine—Asthenia—Sorafenib—kidney cancer	0.000142	0.00117	CcSEcCtD
Adenosine—Cardiac failure—Doxorubicin—kidney cancer	0.000141	0.00116	CcSEcCtD
Adenosine—Syncope—Paclitaxel—kidney cancer	0.000141	0.00116	CcSEcCtD
Adenosine—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000141	0.00116	CcSEcCtD
Adenosine—Hypersensitivity—Sunitinib—kidney cancer	0.00014	0.00115	CcSEcCtD
Adenosine—Vomiting—Erlotinib—kidney cancer	0.00014	0.00115	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000139	0.00115	CcSEcCtD
Adenosine—Rash—Erlotinib—kidney cancer	0.000139	0.00114	CcSEcCtD
Adenosine—Dermatitis—Erlotinib—kidney cancer	0.000139	0.00114	CcSEcCtD
Adenosine—Palpitations—Paclitaxel—kidney cancer	0.000139	0.00114	CcSEcCtD
Adenosine—Headache—Erlotinib—kidney cancer	0.000138	0.00113	CcSEcCtD
Adenosine—Tinnitus—Capecitabine—kidney cancer	0.000138	0.00113	CcSEcCtD
Adenosine—Loss of consciousness—Paclitaxel—kidney cancer	0.000138	0.00113	CcSEcCtD
Adenosine—Pain—Vincristine—kidney cancer	0.000138	0.00113	CcSEcCtD
Adenosine—Paraesthesia—Gemcitabine—kidney cancer	0.000137	0.00113	CcSEcCtD
Adenosine—Flushing—Capecitabine—kidney cancer	0.000137	0.00113	CcSEcCtD
Adenosine—Cardiac disorder—Capecitabine—kidney cancer	0.000137	0.00113	CcSEcCtD
Adenosine—Cough—Paclitaxel—kidney cancer	0.000137	0.00113	CcSEcCtD
Adenosine—Asthenia—Sunitinib—kidney cancer	0.000137	0.00112	CcSEcCtD
Adenosine—Dyspnoea—Gemcitabine—kidney cancer	0.000136	0.00112	CcSEcCtD
Adenosine—Nausea—Vinblastine—kidney cancer	0.000136	0.00112	CcSEcCtD
Adenosine—Somnolence—Gemcitabine—kidney cancer	0.000136	0.00112	CcSEcCtD
Adenosine—Convulsion—Paclitaxel—kidney cancer	0.000136	0.00112	CcSEcCtD
Adenosine—Affect lability—Doxorubicin—kidney cancer	0.000136	0.00112	CcSEcCtD
Adenosine—Nausea—Everolimus—kidney cancer	0.000136	0.00111	CcSEcCtD
Adenosine—Hypertension—Paclitaxel—kidney cancer	0.000135	0.00111	CcSEcCtD
Adenosine—Chest pain—Paclitaxel—kidney cancer	0.000134	0.0011	CcSEcCtD
Adenosine—Mediastinal disorder—Capecitabine—kidney cancer	0.000133	0.0011	CcSEcCtD
Adenosine—Anxiety—Paclitaxel—kidney cancer	0.000133	0.00109	CcSEcCtD
Adenosine—Hypersensitivity—Dactinomycin—kidney cancer	0.000133	0.00109	CcSEcCtD
Adenosine—Arrhythmia—Capecitabine—kidney cancer	0.000132	0.00109	CcSEcCtD
Adenosine—Discomfort—Paclitaxel—kidney cancer	0.000132	0.00109	CcSEcCtD
Adenosine—Cardiac arrest—Doxorubicin—kidney cancer	0.000131	0.00108	CcSEcCtD
Adenosine—Dizziness—Sorafenib—kidney cancer	0.000131	0.00108	CcSEcCtD
Adenosine—Pain—Gemcitabine—kidney cancer	0.000131	0.00108	CcSEcCtD
Adenosine—Nausea—Erlotinib—kidney cancer	0.000131	0.00108	CcSEcCtD
Adenosine—Dry mouth—Paclitaxel—kidney cancer	0.000131	0.00107	CcSEcCtD
Adenosine—Mood swings—Doxorubicin—kidney cancer	0.000131	0.00107	CcSEcCtD
Adenosine—Asthenia—Dactinomycin—kidney cancer	0.000129	0.00106	CcSEcCtD
Adenosine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000128	0.00105	CcSEcCtD
Adenosine—Dysgeusia—Capecitabine—kidney cancer	0.000126	0.00104	CcSEcCtD
Adenosine—Dizziness—Sunitinib—kidney cancer	0.000126	0.00104	CcSEcCtD
Adenosine—Shock—Paclitaxel—kidney cancer	0.000126	0.00104	CcSEcCtD
Adenosine—Vomiting—Sorafenib—kidney cancer	0.000126	0.00104	CcSEcCtD
Adenosine—Tachycardia—Paclitaxel—kidney cancer	0.000125	0.00103	CcSEcCtD
Adenosine—Rash—Sorafenib—kidney cancer	0.000125	0.00103	CcSEcCtD
Adenosine—Dermatitis—Sorafenib—kidney cancer	0.000125	0.00103	CcSEcCtD
Adenosine—Back pain—Capecitabine—kidney cancer	0.000125	0.00102	CcSEcCtD
Adenosine—Headache—Sorafenib—kidney cancer	0.000124	0.00102	CcSEcCtD
Adenosine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000124	0.00102	CcSEcCtD
Adenosine—Vision blurred—Capecitabine—kidney cancer	0.000121	0.000998	CcSEcCtD
Adenosine—Vomiting—Sunitinib—kidney cancer	0.000121	0.000997	CcSEcCtD
Adenosine—Tremor—Capecitabine—kidney cancer	0.000121	0.000992	CcSEcCtD
Adenosine—Rash—Sunitinib—kidney cancer	0.00012	0.000988	CcSEcCtD
Adenosine—Dermatitis—Sunitinib—kidney cancer	0.00012	0.000987	CcSEcCtD
Adenosine—Hypotension—Paclitaxel—kidney cancer	0.00012	0.000984	CcSEcCtD
Adenosine—Headache—Sunitinib—kidney cancer	0.000119	0.000982	CcSEcCtD
Adenosine—Hypersensitivity—Vincristine—kidney cancer	0.000119	0.000977	CcSEcCtD
Adenosine—Nausea—Sorafenib—kidney cancer	0.000118	0.000967	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000117	0.000959	CcSEcCtD
Adenosine—Asthenia—Vincristine—kidney cancer	0.000116	0.000951	CcSEcCtD
Adenosine—Syncope—Capecitabine—kidney cancer	0.000115	0.000949	CcSEcCtD
Adenosine—Paraesthesia—Paclitaxel—kidney cancer	0.000115	0.000945	CcSEcCtD
Adenosine—Vomiting—Dactinomycin—kidney cancer	0.000115	0.000943	CcSEcCtD
Adenosine—Dyspnoea—Paclitaxel—kidney cancer	0.000114	0.000939	CcSEcCtD
Adenosine—Somnolence—Paclitaxel—kidney cancer	0.000114	0.000936	CcSEcCtD
Adenosine—Palpitations—Capecitabine—kidney cancer	0.000114	0.000936	CcSEcCtD
Adenosine—Rash—Dactinomycin—kidney cancer	0.000114	0.000936	CcSEcCtD
Adenosine—Nausea—Sunitinib—kidney cancer	0.000113	0.000931	CcSEcCtD
Adenosine—Loss of consciousness—Capecitabine—kidney cancer	0.000113	0.000931	CcSEcCtD
Adenosine—Cough—Capecitabine—kidney cancer	0.000112	0.000924	CcSEcCtD
Adenosine—Hypertension—Capecitabine—kidney cancer	0.000111	0.000914	CcSEcCtD
Adenosine—Pollakiuria—Doxorubicin—kidney cancer	0.00011	0.000905	CcSEcCtD
Adenosine—Asthenia—Gemcitabine—kidney cancer	0.00011	0.000902	CcSEcCtD
Adenosine—Chest pain—Capecitabine—kidney cancer	0.00011	0.000901	CcSEcCtD
Adenosine—Pain—Paclitaxel—kidney cancer	0.000109	0.0009	CcSEcCtD
Adenosine—Anxiety—Capecitabine—kidney cancer	0.000109	0.000898	CcSEcCtD
Adenosine—Discomfort—Capecitabine—kidney cancer	0.000108	0.000891	CcSEcCtD
Adenosine—Dry mouth—Capecitabine—kidney cancer	0.000107	0.000882	CcSEcCtD
Adenosine—Nausea—Dactinomycin—kidney cancer	0.000107	0.000881	CcSEcCtD
Adenosine—Dizziness—Vincristine—kidney cancer	0.000107	0.000877	CcSEcCtD
Adenosine—Drowsiness—Doxorubicin—kidney cancer	0.000106	0.000873	CcSEcCtD
Adenosine—Shock—Capecitabine—kidney cancer	0.000103	0.00085	CcSEcCtD
Adenosine—Tachycardia—Capecitabine—kidney cancer	0.000103	0.000843	CcSEcCtD
Adenosine—Vomiting—Vincristine—kidney cancer	0.000102	0.000843	CcSEcCtD
Adenosine—Sweating—Doxorubicin—kidney cancer	0.000102	0.000837	CcSEcCtD
Adenosine—Urticaria—Paclitaxel—kidney cancer	0.000102	0.000836	CcSEcCtD
Adenosine—Rash—Vincristine—kidney cancer	0.000102	0.000836	CcSEcCtD
Adenosine—Hyperhidrosis—Capecitabine—kidney cancer	0.000102	0.000835	CcSEcCtD
Adenosine—Dermatitis—Vincristine—kidney cancer	0.000102	0.000835	CcSEcCtD
Adenosine—Headache—Vincristine—kidney cancer	0.000101	0.00083	CcSEcCtD
Adenosine—Hypotension—Capecitabine—kidney cancer	9.82e-05	0.000807	CcSEcCtD
Adenosine—Vomiting—Gemcitabine—kidney cancer	9.72e-05	0.0008	CcSEcCtD
Adenosine—Bradycardia—Doxorubicin—kidney cancer	9.7e-05	0.000798	CcSEcCtD
Adenosine—Rash—Gemcitabine—kidney cancer	9.64e-05	0.000793	CcSEcCtD
Adenosine—Dermatitis—Gemcitabine—kidney cancer	9.63e-05	0.000792	CcSEcCtD
Adenosine—Headache—Gemcitabine—kidney cancer	9.58e-05	0.000788	CcSEcCtD
Adenosine—Nausea—Vincristine—kidney cancer	9.57e-05	0.000787	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.57e-05	0.000787	CcSEcCtD
Adenosine—Hypoaesthesia—Doxorubicin—kidney cancer	9.49e-05	0.00078	CcSEcCtD
Adenosine—Paraesthesia—Capecitabine—kidney cancer	9.43e-05	0.000776	CcSEcCtD
Adenosine—Hypersensitivity—Paclitaxel—kidney cancer	9.43e-05	0.000776	CcSEcCtD
Adenosine—Dyspnoea—Capecitabine—kidney cancer	9.37e-05	0.00077	CcSEcCtD
Adenosine—Asthenia—Paclitaxel—kidney cancer	9.19e-05	0.000755	CcSEcCtD
Adenosine—Nausea—Gemcitabine—kidney cancer	9.08e-05	0.000747	CcSEcCtD
Adenosine—Pain—Capecitabine—kidney cancer	8.98e-05	0.000739	CcSEcCtD
Adenosine—Tinnitus—Doxorubicin—kidney cancer	8.89e-05	0.000731	CcSEcCtD
Adenosine—Flushing—Doxorubicin—kidney cancer	8.85e-05	0.000728	CcSEcCtD
Adenosine—Cardiac disorder—Doxorubicin—kidney cancer	8.85e-05	0.000728	CcSEcCtD
Adenosine—Mediastinal disorder—Doxorubicin—kidney cancer	8.59e-05	0.000707	CcSEcCtD
Adenosine—Arrhythmia—Doxorubicin—kidney cancer	8.52e-05	0.0007	CcSEcCtD
Adenosine—Dizziness—Paclitaxel—kidney cancer	8.47e-05	0.000696	CcSEcCtD
Adenosine—Urticaria—Capecitabine—kidney cancer	8.35e-05	0.000686	CcSEcCtD
Adenosine—Tension—Doxorubicin—kidney cancer	8.14e-05	0.00067	CcSEcCtD
Adenosine—Vomiting—Paclitaxel—kidney cancer	8.14e-05	0.000669	CcSEcCtD
Adenosine—Dysgeusia—Doxorubicin—kidney cancer	8.13e-05	0.000668	CcSEcCtD
Adenosine—Rash—Paclitaxel—kidney cancer	8.07e-05	0.000664	CcSEcCtD
Adenosine—Dermatitis—Paclitaxel—kidney cancer	8.07e-05	0.000663	CcSEcCtD
Adenosine—Nervousness—Doxorubicin—kidney cancer	8.06e-05	0.000663	CcSEcCtD
Adenosine—Back pain—Doxorubicin—kidney cancer	8.03e-05	0.00066	CcSEcCtD
Adenosine—Headache—Paclitaxel—kidney cancer	8.02e-05	0.00066	CcSEcCtD
Adenosine—Vision blurred—Doxorubicin—kidney cancer	7.82e-05	0.000643	CcSEcCtD
Adenosine—Adenosine triphosphate—ABCB1—kidney cancer	7.76e-05	0.0222	CrCbGaD
Adenosine—Hypersensitivity—Capecitabine—kidney cancer	7.74e-05	0.000637	CcSEcCtD
Adenosine—Agitation—Doxorubicin—kidney cancer	7.63e-05	0.000627	CcSEcCtD
Adenosine—Nausea—Paclitaxel—kidney cancer	7.6e-05	0.000625	CcSEcCtD
Adenosine—Asthenia—Capecitabine—kidney cancer	7.54e-05	0.00062	CcSEcCtD
Adenosine—Syncope—Doxorubicin—kidney cancer	7.44e-05	0.000612	CcSEcCtD
Adenosine—Palpitations—Doxorubicin—kidney cancer	7.33e-05	0.000603	CcSEcCtD
Adenosine—Loss of consciousness—Doxorubicin—kidney cancer	7.29e-05	0.0006	CcSEcCtD
Adenosine—Cough—Doxorubicin—kidney cancer	7.24e-05	0.000596	CcSEcCtD
Adenosine—Convulsion—Doxorubicin—kidney cancer	7.19e-05	0.000591	CcSEcCtD
Adenosine—Hypertension—Doxorubicin—kidney cancer	7.16e-05	0.000589	CcSEcCtD
Adenosine—Chest pain—Doxorubicin—kidney cancer	7.07e-05	0.000581	CcSEcCtD
Adenosine—Anxiety—Doxorubicin—kidney cancer	7.04e-05	0.000579	CcSEcCtD
Adenosine—Discomfort—Doxorubicin—kidney cancer	6.98e-05	0.000574	CcSEcCtD
Adenosine—Dizziness—Capecitabine—kidney cancer	6.95e-05	0.000571	CcSEcCtD
Adenosine—Dry mouth—Doxorubicin—kidney cancer	6.91e-05	0.000568	CcSEcCtD
Adenosine—Anaphylactic shock—Doxorubicin—kidney cancer	6.77e-05	0.000557	CcSEcCtD
Adenosine—Vomiting—Capecitabine—kidney cancer	6.68e-05	0.000549	CcSEcCtD
Adenosine—Shock—Doxorubicin—kidney cancer	6.66e-05	0.000548	CcSEcCtD
Adenosine—ADORA2A—GPCR ligand binding—ANXA1—kidney cancer	6.64e-05	0.000893	CbGpPWpGaD
Adenosine—Rash—Capecitabine—kidney cancer	6.62e-05	0.000545	CcSEcCtD
Adenosine—Dermatitis—Capecitabine—kidney cancer	6.62e-05	0.000544	CcSEcCtD
Adenosine—Tachycardia—Doxorubicin—kidney cancer	6.61e-05	0.000544	CcSEcCtD
Adenosine—Headache—Capecitabine—kidney cancer	6.58e-05	0.000541	CcSEcCtD
Adenosine—Hyperhidrosis—Doxorubicin—kidney cancer	6.55e-05	0.000538	CcSEcCtD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	6.51e-05	0.000875	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AMER1—kidney cancer	6.37e-05	0.000857	CbGpPWpGaD
Adenosine—ADK—Metabolism—SCARB1—kidney cancer	6.35e-05	0.000854	CbGpPWpGaD
Adenosine—ADA—Metabolism—CA9—kidney cancer	6.33e-05	0.000851	CbGpPWpGaD
Adenosine—Hypotension—Doxorubicin—kidney cancer	6.33e-05	0.00052	CcSEcCtD
Adenosine—ADK—Metabolism—PTGS1—kidney cancer	6.29e-05	0.000845	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—GPC3—kidney cancer	6.28e-05	0.000844	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CER1—kidney cancer	6.28e-05	0.000844	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KIT—kidney cancer	6.27e-05	0.000843	CbGpPWpGaD
Adenosine—Nausea—Capecitabine—kidney cancer	6.24e-05	0.000513	CcSEcCtD
Adenosine—ADORA2B—Signaling by GPCR—ITPR2—kidney cancer	6.2e-05	0.000833	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—AKAP13—kidney cancer	6.2e-05	0.000833	CbGpPWpGaD
Adenosine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.17e-05	0.000507	CcSEcCtD
Adenosine—ADK—Metabolism—PSMD7—kidney cancer	6.17e-05	0.000829	CbGpPWpGaD
Adenosine—Paraesthesia—Doxorubicin—kidney cancer	6.08e-05	0.0005	CcSEcCtD
Adenosine—Dyspnoea—Doxorubicin—kidney cancer	6.04e-05	0.000497	CcSEcCtD
Adenosine—Somnolence—Doxorubicin—kidney cancer	6.02e-05	0.000495	CcSEcCtD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—BRAF—kidney cancer	5.9e-05	0.000793	CbGpPWpGaD
Adenosine—ADK—Metabolism—BCHE—kidney cancer	5.85e-05	0.000786	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—ITPR2—kidney cancer	5.8e-05	0.00078	CbGpPWpGaD
Adenosine—Pain—Doxorubicin—kidney cancer	5.79e-05	0.000476	CcSEcCtD
Adenosine—ADORA2A—Signaling Pathways—LATS1—kidney cancer	5.79e-05	0.000778	CbGpPWpGaD
Adenosine—ADK—Metabolism—SLC5A5—kidney cancer	5.78e-05	0.000776	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—ANXA1—kidney cancer	5.72e-05	0.000768	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—JUN—kidney cancer	5.67e-05	0.000762	CbGpPWpGaD
Adenosine—ADK—Metabolism—SLC2A1—kidney cancer	5.58e-05	0.00075	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	5.53e-05	0.000744	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—PTEN—kidney cancer	5.49e-05	0.000737	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—TSC2—kidney cancer	5.46e-05	0.000734	CbGpPWpGaD
Adenosine—ADA—Metabolism—CRABP1—kidney cancer	5.38e-05	0.000723	CbGpPWpGaD
Adenosine—Urticaria—Doxorubicin—kidney cancer	5.38e-05	0.000442	CcSEcCtD
Adenosine—ADORA1—Signaling Pathways—CER1—kidney cancer	5.34e-05	0.000718	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GPC3—kidney cancer	5.34e-05	0.000718	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SFRP2—kidney cancer	5.34e-05	0.000718	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—RAF1—kidney cancer	5.32e-05	0.000715	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—ITPR2—kidney cancer	5.27e-05	0.000708	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AKAP13—kidney cancer	5.27e-05	0.000708	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—ANXA1—kidney cancer	5.19e-05	0.000698	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—TP53—kidney cancer	5.03e-05	0.000677	CbGpPWpGaD
Adenosine—ADA—Metabolism—ITPR2—kidney cancer	5e-05	0.000672	CbGpPWpGaD
Adenosine—Hypersensitivity—Doxorubicin—kidney cancer	4.99e-05	0.00041	CcSEcCtD
Adenosine—ADORA2B—GPCR ligand binding—POMC—kidney cancer	4.96e-05	0.000666	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—RAF1—kidney cancer	4.92e-05	0.000662	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AMER1—kidney cancer	4.92e-05	0.000661	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ERBB2—kidney cancer	4.87e-05	0.000655	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—ANXA1—kidney cancer	4.86e-05	0.000653	CbGpPWpGaD
Adenosine—Asthenia—Doxorubicin—kidney cancer	4.86e-05	0.0004	CcSEcCtD
Adenosine—ADORA2A—Signaling by NGF—KIT—kidney cancer	4.83e-05	0.000649	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MTOR—kidney cancer	4.81e-05	0.000646	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AKAP13—kidney cancer	4.78e-05	0.000643	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—POMC—kidney cancer	4.78e-05	0.000642	CbGpPWpGaD
Adenosine—ADK—Metabolism—GSTP1—kidney cancer	4.65e-05	0.000625	CbGpPWpGaD
Adenosine—ADA—Metabolism—ACHE—kidney cancer	4.56e-05	0.000613	CbGpPWpGaD
Adenosine—ADA—Metabolism—GSTT1—kidney cancer	4.56e-05	0.000613	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SFRP2—kidney cancer	4.54e-05	0.00061	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—BRAF—kidney cancer	4.54e-05	0.00061	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1B—kidney cancer	4.51e-05	0.000606	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—ITPR2—kidney cancer	4.48e-05	0.000602	CbGpPWpGaD
Adenosine—Dizziness—Doxorubicin—kidney cancer	4.48e-05	0.000368	CcSEcCtD
Adenosine—ADORA1—Signaling by GPCR—ANXA1—kidney cancer	4.42e-05	0.000593	CbGpPWpGaD
Adenosine—ADK—Metabolism—ABCB1—kidney cancer	4.4e-05	0.000592	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—JUN—kidney cancer	4.38e-05	0.000589	CbGpPWpGaD
Adenosine—ADA—Metabolism—SCARB1—kidney cancer	4.32e-05	0.00058	CbGpPWpGaD
Adenosine—Vomiting—Doxorubicin—kidney cancer	4.31e-05	0.000354	CcSEcCtD
Adenosine—ADORA2B—Signaling Pathways—AKAP13—kidney cancer	4.3e-05	0.000579	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CASP2—kidney cancer	4.3e-05	0.000579	CbGpPWpGaD
Adenosine—ADK—Metabolism—GSTM1—kidney cancer	4.28e-05	0.000575	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTGS1—kidney cancer	4.28e-05	0.000575	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	4.27e-05	0.000574	CbGpPWpGaD
Adenosine—Rash—Doxorubicin—kidney cancer	4.27e-05	0.000351	CcSEcCtD
Adenosine—Dermatitis—Doxorubicin—kidney cancer	4.27e-05	0.000351	CcSEcCtD
Adenosine—Headache—Doxorubicin—kidney cancer	4.24e-05	0.000349	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—PTEN—kidney cancer	4.24e-05	0.000569	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—POMC—kidney cancer	4.21e-05	0.000566	CbGpPWpGaD
Adenosine—ADA—Metabolism—PSMD7—kidney cancer	4.19e-05	0.000564	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PTEN—kidney cancer	4.15e-05	0.000558	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GPC3—kidney cancer	4.12e-05	0.000554	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CER1—kidney cancer	4.12e-05	0.000554	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—ITPR2—kidney cancer	4.07e-05	0.000547	CbGpPWpGaD
Adenosine—ADK—Metabolism—CYP1A1—kidney cancer	4.05e-05	0.000545	CbGpPWpGaD
Adenosine—Nausea—Doxorubicin—kidney cancer	4.02e-05	0.000331	CcSEcCtD
Adenosine—ADA—Metabolism—BCHE—kidney cancer	3.97e-05	0.000534	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—GRB7—kidney cancer	3.94e-05	0.000529	CbGpPWpGaD
Adenosine—ADA—Metabolism—SLC5A5—kidney cancer	3.93e-05	0.000528	CbGpPWpGaD
Adenosine—ADA—Metabolism—SLC2A1—kidney cancer	3.79e-05	0.00051	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—RAF1—kidney cancer	3.79e-05	0.000509	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—RELA—kidney cancer	3.77e-05	0.000507	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—ANXA1—kidney cancer	3.75e-05	0.000505	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—ERBB2—kidney cancer	3.75e-05	0.000504	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—TP53—kidney cancer	3.74e-05	0.000503	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—MTOR—kidney cancer	3.7e-05	0.000497	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ITPR2—kidney cancer	3.66e-05	0.000492	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKAP13—kidney cancer	3.66e-05	0.000492	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CASP2—kidney cancer	3.66e-05	0.000492	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAPK3—kidney cancer	3.55e-05	0.000477	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SFRP2—kidney cancer	3.51e-05	0.000471	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—CDKN1B—kidney cancer	3.47e-05	0.000466	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—CTNNB1—kidney cancer	3.41e-05	0.000458	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—ANXA1—kidney cancer	3.41e-05	0.000458	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAPK1—kidney cancer	3.38e-05	0.000454	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GRB7—kidney cancer	3.35e-05	0.00045	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CTNNA1—kidney cancer	3.32e-05	0.000446	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HSPB1—kidney cancer	3.3e-05	0.000443	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EIF4EBP1—kidney cancer	3.3e-05	0.000443	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—POMC—kidney cancer	3.25e-05	0.000437	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—PTEN—kidney cancer	3.2e-05	0.000429	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—kidney cancer	3.19e-05	0.000429	CbGpPWpGaD
Adenosine—ADA—Metabolism—GSTP1—kidney cancer	3.16e-05	0.000425	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ITPR2—kidney cancer	3.11e-05	0.000418	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PSMD7—kidney cancer	3.07e-05	0.000412	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TSC1—kidney cancer	3.07e-05	0.000412	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ANXA1—kidney cancer	3.07e-05	0.000412	CbGpPWpGaD
Adenosine—ADK—Metabolism—POMC—kidney cancer	3.02e-05	0.000406	CbGpPWpGaD
Adenosine—ADA—Metabolism—ABCB1—kidney cancer	2.99e-05	0.000402	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FLT1—kidney cancer	2.97e-05	0.000399	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—kidney cancer	2.93e-05	0.000394	CbGpPWpGaD
Adenosine—ADA—Metabolism—GSTM1—kidney cancer	2.91e-05	0.000391	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—TP53—kidney cancer	2.89e-05	0.000389	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CASP2—kidney cancer	2.83e-05	0.00038	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKAP13—kidney cancer	2.83e-05	0.00038	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CTNNA1—kidney cancer	2.82e-05	0.000379	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HSPB1—kidney cancer	2.81e-05	0.000377	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EIF4EBP1—kidney cancer	2.81e-05	0.000377	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—POMC—kidney cancer	2.8e-05	0.000376	CbGpPWpGaD
Adenosine—ADA—Metabolism—CYP1A1—kidney cancer	2.76e-05	0.00037	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PAK1—kidney cancer	2.75e-05	0.00037	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—JUNB—kidney cancer	2.75e-05	0.00037	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—MAPK3—kidney cancer	2.73e-05	0.000367	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ANXA1—kidney cancer	2.61e-05	0.000351	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TSC1—kidney cancer	2.61e-05	0.000351	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PSMD7—kidney cancer	2.61e-05	0.000351	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—MAPK1—kidney cancer	2.6e-05	0.000349	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GRB7—kidney cancer	2.58e-05	0.000347	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—POMC—kidney cancer	2.54e-05	0.000342	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FLT1—kidney cancer	2.53e-05	0.000339	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—KRAS—kidney cancer	2.45e-05	0.00033	CbGpPWpGaD
Adenosine—ADK—Metabolism—PTGS2—kidney cancer	2.41e-05	0.000324	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ITPR2—kidney cancer	2.4e-05	0.000323	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—POMC—kidney cancer	2.38e-05	0.00032	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—JUNB—kidney cancer	2.34e-05	0.000315	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PAK1—kidney cancer	2.34e-05	0.000315	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—PIK3CA—kidney cancer	2.25e-05	0.000303	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IGF2—kidney cancer	2.25e-05	0.000303	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CDKN2B—kidney cancer	2.24e-05	0.000301	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CTNNA1—kidney cancer	2.18e-05	0.000293	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IGF1R—kidney cancer	2.18e-05	0.000293	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EIF4EBP1—kidney cancer	2.17e-05	0.000291	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HSPB1—kidney cancer	2.17e-05	0.000291	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—POMC—kidney cancer	2.16e-05	0.000291	CbGpPWpGaD
Adenosine—ADK—Metabolism—PTEN—kidney cancer	2.1e-05	0.000283	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—RAF1—kidney cancer	2.1e-05	0.000282	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—IL2—kidney cancer	2.07e-05	0.000278	CbGpPWpGaD
Adenosine—ADA—Metabolism—POMC—kidney cancer	2.05e-05	0.000276	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ANXA1—kidney cancer	2.01e-05	0.000271	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TSC1—kidney cancer	2.01e-05	0.000271	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PSMD7—kidney cancer	2.01e-05	0.000271	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FLT1—kidney cancer	1.95e-05	0.000262	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IGF2—kidney cancer	1.91e-05	0.000257	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CDKN2B—kidney cancer	1.91e-05	0.000256	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL2—kidney cancer	1.88e-05	0.000253	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IGF1R—kidney cancer	1.85e-05	0.000249	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—POMC—kidney cancer	1.84e-05	0.000247	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PAK1—kidney cancer	1.81e-05	0.000243	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—JUNB—kidney cancer	1.81e-05	0.000243	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HIF1A—kidney cancer	1.79e-05	0.000241	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TSC2—kidney cancer	1.79e-05	0.00024	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—RAF1—kidney cancer	1.78e-05	0.00024	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—IL2—kidney cancer	1.76e-05	0.000237	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KDR—kidney cancer	1.71e-05	0.00023	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—POMC—kidney cancer	1.67e-05	0.000224	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTGS2—kidney cancer	1.64e-05	0.00022	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL2—kidney cancer	1.6e-05	0.000215	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—APC—kidney cancer	1.58e-05	0.000212	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KIT—kidney cancer	1.58e-05	0.000212	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HIF1A—kidney cancer	1.52e-05	0.000205	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TSC2—kidney cancer	1.52e-05	0.000204	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—MAPK3—kidney cancer	1.51e-05	0.000203	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—POMC—kidney cancer	1.5e-05	0.000202	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—BRAF—kidney cancer	1.48e-05	0.000199	CbGpPWpGaD
Adenosine—ADK—Metabolism—PIK3CA—kidney cancer	1.48e-05	0.000199	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IGF2—kidney cancer	1.48e-05	0.000199	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CDKN2B—kidney cancer	1.47e-05	0.000198	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KDR—kidney cancer	1.46e-05	0.000196	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—MAPK1—kidney cancer	1.44e-05	0.000193	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IGF1R—kidney cancer	1.43e-05	0.000192	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTEN—kidney cancer	1.43e-05	0.000192	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—RAF1—kidney cancer	1.38e-05	0.000185	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3CA—kidney cancer	1.37e-05	0.000185	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—IL2—kidney cancer	1.36e-05	0.000183	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—KRAS—kidney cancer	1.36e-05	0.000183	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—APC—kidney cancer	1.34e-05	0.00018	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KIT—kidney cancer	1.34e-05	0.00018	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—MAPK3—kidney cancer	1.29e-05	0.000173	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—POMC—kidney cancer	1.28e-05	0.000172	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—BRAF—kidney cancer	1.26e-05	0.00017	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CA—kidney cancer	1.25e-05	0.000168	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RAF1—kidney cancer	1.24e-05	0.000167	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL2—kidney cancer	1.23e-05	0.000166	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RELA—kidney cancer	1.23e-05	0.000166	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ERBB2—kidney cancer	1.23e-05	0.000165	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—MAPK1—kidney cancer	1.22e-05	0.000164	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MTOR—kidney cancer	1.21e-05	0.000163	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HIF1A—kidney cancer	1.18e-05	0.000158	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TSC2—kidney cancer	1.17e-05	0.000158	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CA—kidney cancer	1.17e-05	0.000157	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—KRAS—kidney cancer	1.16e-05	0.000155	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CDKN1B—kidney cancer	1.14e-05	0.000153	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KDR—kidney cancer	1.13e-05	0.000151	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL2—kidney cancer	1.11e-05	0.000149	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCND1—kidney cancer	1.08e-05	0.000146	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—JUN—kidney cancer	1.08e-05	0.000145	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CTNNB1—kidney cancer	1.07e-05	0.000144	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CA—kidney cancer	1.06e-05	0.000143	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RAF1—kidney cancer	1.05e-05	0.000142	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RELA—kidney cancer	1.05e-05	0.000141	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PTEN—kidney cancer	1.05e-05	0.00014	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ERBB2—kidney cancer	1.04e-05	0.00014	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KIT—kidney cancer	1.04e-05	0.000139	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APC—kidney cancer	1.04e-05	0.000139	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MTOR—kidney cancer	1.03e-05	0.000138	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CA—kidney cancer	1.01e-05	0.000135	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—MAPK3—kidney cancer	9.93e-06	0.000133	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—POMC—kidney cancer	9.87e-06	0.000133	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—BRAF—kidney cancer	9.74e-06	0.000131	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CDKN1B—kidney cancer	9.65e-06	0.00013	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL2—kidney cancer	9.45e-06	0.000127	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—MAPK1—kidney cancer	9.44e-06	0.000127	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—VEGFA—kidney cancer	9.44e-06	0.000127	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCND1—kidney cancer	9.21e-06	0.000124	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—JUN—kidney cancer	9.19e-06	0.000124	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CTNNB1—kidney cancer	9.12e-06	0.000123	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CA—kidney cancer	9.02e-06	0.000121	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MAPK3—kidney cancer	8.93e-06	0.00012	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—KRAS—kidney cancer	8.92e-06	0.00012	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTEN—kidney cancer	8.89e-06	0.000119	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MYC—kidney cancer	8.69e-06	0.000117	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MAPK1—kidney cancer	8.5e-06	0.000114	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CA—kidney cancer	8.2e-06	0.00011	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RAF1—kidney cancer	8.13e-06	0.000109	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RELA—kidney cancer	8.1e-06	0.000109	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ERBB2—kidney cancer	8.05e-06	0.000108	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—VEGFA—kidney cancer	8.03e-06	0.000108	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KRAS—kidney cancer	8.03e-06	0.000108	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MTOR—kidney cancer	7.94e-06	0.000107	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MAPK3—kidney cancer	7.59e-06	0.000102	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CDKN1B—kidney cancer	7.45e-06	0.0001	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MYC—kidney cancer	7.39e-06	9.93e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CA—kidney cancer	7.37e-06	9.91e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL2—kidney cancer	7.29e-06	9.8e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MAPK1—kidney cancer	7.23e-06	9.71e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TP53—kidney cancer	7.13e-06	9.59e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCND1—kidney cancer	7.11e-06	9.56e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—JUN—kidney cancer	7.09e-06	9.54e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CTNNB1—kidney cancer	7.04e-06	9.46e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTEN—kidney cancer	6.86e-06	9.22e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KRAS—kidney cancer	6.83e-06	9.17e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CA—kidney cancer	6.27e-06	8.43e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—VEGFA—kidney cancer	6.2e-06	8.33e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TP53—kidney cancer	6.07e-06	8.15e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MAPK3—kidney cancer	5.86e-06	7.88e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MYC—kidney cancer	5.7e-06	7.66e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MAPK1—kidney cancer	5.58e-06	7.5e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KRAS—kidney cancer	5.27e-06	7.08e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CA—kidney cancer	4.84e-06	6.51e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TP53—kidney cancer	4.68e-06	6.29e-05	CbGpPWpGaD
